SATINIQUE ANTI DANDRUFF SCALP AND HAIR- salicylic acid liquid

Satinique Anti Dandruff Scalp and Hair by

Drug Labeling and Warnings

Satinique Anti Dandruff Scalp and Hair by is a Otc medication manufactured, distributed, or labeled by Access Business Group LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active Ingredients

Salicylic Acid 2.0%

Purpose

Anti-Dandruff

Uses

• Helps prevent recurrence of scalp itching, flaking, and scaling associated with dandruff.

Warnings

For external use only

Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

If condition worsensor does not improve after regular use of this product as directed, consult a doctor.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Wet hair
• Apply shampoo and work into a lather
• Rinse thoroughly
• For best results, use at least twice a week or as directed by a doctor.

Inactive ingredients:

Water, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Cocamidopropyl Hydroxysultaine, Sodium Chloride, Cetyl Alcohol, Acrylates Copolymer, Fragrance, Glycerin, Sodium Benzoate, Sodium Lauroyl Sarcosinate, Benzyl Alcohol, Sodium Hydroxide, Guar Hydroxypropyltrimonium Chloride, Polystyrene, Caprylic/-Capric Triglyceride, Lauric Acid, Tetrasodium EDTA, Polyquaternium-39, Creatine, Xanthan Gum, Ethylhexyglycerin, Phenoxyethanol, Butylene Glycol, Glycereth- 26, C11-15 Pareth-40, Tocopherol, Lecithin, C11-15 Alketh-7, Zingiber Officinale (Ginger) Root Extract, Helianthus Annuus (Sunflower) Seed Oil, Chenopodium Quinoa Seed Extract, Argania Spinosa Kernel Oil, Poloxamer 331, Hydrolyzed Adansonia Digitata Seed Extract, Myristic Acid, PPG-12-Buteth-16, Sodium Hyaluronate, Ceramide NP, Propylene Glycol, Phytosphingosine, Beta- Sitosterol, Chlorphenesin, Hydrogenated Lecithin, Potassium Sorbate, Citronellol, Geraniol, Hexyl Cinnamal, Limonene, Linalool

Questions?

USA: 1-800-253-6500

Package Labeling:

Package Labeling:

INGREDIENTS AND APPEARANCE

SATINIQUE ANTI DANDRUFF SCALP AND HAIR 
salicylic acid liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 10056-536
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	20 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)
COCAMIDOPROPYL HYDROXYSULTAINE (UNII: 62V75NI93W)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
CETYL ALCOHOL (UNII: 936JST6JCN)
GLYCERIN (UNII: PDC6A3C0OX)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)
BENZYL ALCOHOL (UNII: LKG8494WBH)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
GUAR HYDROXYPROPYLTRIMONIUM CHLORIDE (UNII: B16G315W7A)
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
LAURIC ACID (UNII: 1160N9NU9U)
EDETATE SODIUM (UNII: MP1J8420LU)
CREATINE (UNII: MU72812GK0)
XANTHAN GUM (UNII: TTV12P4NEE)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
GLYCERETH-26 (UNII: NNE56F2N14)
C11-15 PARETH-40 (UNII: L774F88277)
TOCOPHEROL (UNII: R0ZB2556P8)
C11-15 ALKETH-7 (UNII: 261HPE0IS3)
GINGER (UNII: C5529G5JPQ)
SUNFLOWER OIL (UNII: 3W1JG795YI)
CHENOPODIUM QUINOA SEED (UNII: OO4K72NZ2X)
ARGAN OIL (UNII: 4V59G5UW9X)
POLOXAMER 331 (UNII: IS93EQR73R)
MYRISTIC ACID (UNII: 0I3V7S25AW)
PPG-12-BUTETH-16 (UNII: 58CG7042J1)
HYALURONATE SODIUM (UNII: YSE9PPT4TH)
CERAMIDE NP (UNII: 4370DF050B)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)
.BETA.-SITOSTEROL (UNII: S347WMO6M4)
CHLORPHENESIN (UNII: I670DAL4SZ)
POTASSIUM SORBATE (UNII: 1VPU26JZZ4)
.BETA.-CITRONELLOL, (R)- (UNII: P01OUT964K)
GERANIOL (UNII: L837108USY)
.ALPHA.-HEXYLCINNAMALDEHYDE (UNII: 7X6O37OK2I)
LIMONENE, (+)- (UNII: GFD7C86Q1W)
LINALOOL, (+/-)- (UNII: D81QY6I88E)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 10056-536-00	280 mL in 1 CONTAINER; Type 0: Not a Combination Product	02/01/2025
2	NDC: 10056-536-01	750 mL in 1 CONTAINER; Type 0: Not a Combination Product	02/01/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M032	02/01/2025

Labeler - Access Business Group LLC (839830713)